verbio Vereinigte BioEnergie (VBK) AI Stock Analysis

• Market Cap: €972.94M
• Dividend Yield: 1.12%
• Average Volume (3M): 165.84K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.24
• Revenue Growth: 8.65%
• EPS Growth: -379.83%
• Country: DE
• Employees: 1,521
• Sector: Energy
• Sector Strength: 52
• Industry: Chemicals - Specialty
• EPS (TTM): -0.06
• Shares Outstanding: 63,715,480
• 10 Day Avg. Volume: 196,028
• 30 Day Avg. Volume: 165,844
• PEG Ratio: <0.01
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.49
• P/FCF Ratio: -6.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €15.50
• Price Target Upside: -13.07% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 57 Neutral
• Price Target: €18.00 ▲(0.95% Upside)

The overall score reflects significant financial challenges, with declining profitability and cash flow issues being the most impactful factors. Technical analysis shows strong bullish momentum, but overbought conditions suggest caution. The earnings call provided some positive insights, particularly in production and EBITDA improvements, but increased net debt and segment losses remain concerns.

Positive Factors

Production Efficiency

High capacity utilization in biodiesel production indicates operational efficiency, supporting long-term cost management and competitive positioning.

Product Diversification

Growth in ethanol and biomethane production enhances product diversification, reducing dependency on a single product line and improving resilience.

EBITDA Improvement

Significant EBITDA improvement reflects better cost management and revenue generation, which can enhance financial stability and investor confidence.

Negative Factors

Rising Net Debt

Increased net debt poses a risk to financial flexibility, potentially limiting future investment opportunities and increasing financial risk.

Bioethanol Segment Loss

Continued losses in the Bioethanol segment highlight operational challenges and may hinder overall profitability if not addressed.

Cash Flow Challenges

Negative free cash flow indicates cash generation issues, which can impact the company's ability to fund operations and growth initiatives.

verbio Vereinigte BioEnergie Business Overview & Revenue Model

Company Description

VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil corporations, oil traders, independent filling stations, haulage companies, public utilities, and vehicle fleets. VERBIO Vereinigte BioEnergie AG was founded in 2006 and is headquartered in Leipzig, Germany.

How the Company Makes Money

VBK generates revenue primarily through the sale of renewable energy products, including biodiesel and biomethane, which are sold to various industries and consumers. The company benefits from government subsidies and incentives aimed at promoting renewable energy use, which enhances its profitability. Additionally, VBK has established key partnerships with agricultural producers for the sourcing of raw materials, such as organic waste and crops, which further supports its production processes. The diversification of its biofuel offerings and investment in advanced technologies also contribute to its revenue streams, positioning VBK as a competitive player in the bioenergy market.

verbio Vereinigte BioEnergie Financial Statement Overview

Summary

The company is facing significant financial challenges with declining profitability and inconsistent revenue growth. The balance sheet is stable but shows stress with negative returns on equity. Cash flow issues are evident, with negative free cash flow and reduced cash generation efficiency.

Income Statement

The income statement shows a concerning trend with declining profitability. The company has experienced a significant drop in gross profit margin from 33.7% in 2021 to 2.3% in 2025. Net profit margin has also turned negative, indicating losses. Revenue growth has been inconsistent, with a recent positive growth of 6.1% in 2025 after previous declines. The EBIT and EBITDA margins have deteriorated significantly, reflecting operational challenges.

Balance Sheet

The balance sheet remains relatively stable with a manageable debt-to-equity ratio of 0.36 in 2025, up from 0.06 in 2021. However, the return on equity has turned negative, indicating inefficiencies in generating returns from equity. The equity ratio remains healthy, suggesting a solid capital structure despite the recent performance issues.

Cash Flow

Cash flow analysis reveals challenges, with free cash flow turning negative in recent years. The operating cash flow to net income ratio has decreased, indicating reduced cash generation efficiency. The free cash flow to net income ratio is negative, highlighting cash flow struggles relative to earnings.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.58B	1.58B	1.67B	1.97B	1.81B	1.03B
Gross Profit	102.56M	37.12M	292.45M	381.91M	626.92M	271.64M
EBITDA	15.40M	-54.41M	122.92M	242.68M	494.81M	166.48M
Net Income	-138.01M	-138.01M	19.96M	132.02M	315.63M	93.20M
Balance Sheet
Total Assets	1.30B	1.30B	1.38B	1.30B	1.13B	678.62M
Cash, Cash Equivalents and Short-Term Investments	64.41M	64.41M	126.70M	170.31M	300.50M	105.34M
Total Debt	268.86M	268.86M	194.20M	189.97M	49.39M	46.48M
Total Liabilities	527.61M	527.61M	449.54M	385.36M	310.16M	168.75M
Stockholders Equity	746.29M	746.29M	925.67M	909.47M	816.23M	507.85M
Cash Flow
Free Cash Flow	-118.66M	-117.96M	-54.38M	-177.12M	210.15M	49.90M
Operating Cash Flow	13.88M	13.88M	116.78M	26.09M	325.03M	117.18M
Investing Cash Flow	-120.06M	-120.06M	-144.90M	-266.43M	-113.62M	-46.56M
Financing Cash Flow	49.88M	49.88M	-19.53M	112.21M	-18.48M	-18.76M

verbio Vereinigte BioEnergie Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 17.83
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Positive. The current price of 17.83 is above the 20-day moving average (MA) of 16.64, above the 50-day MA of 14.53, and above the 200-day MA of 11.33, indicating a bullish trend. The MACD of 0.69 indicates Positive momentum. The RSI at 68.59 is Neutral, neither overbought nor oversold. The STOCH value of 85.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:VBK.

verbio Vereinigte BioEnergie Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACT	70 Neutral	€1.57B	26.96	29.12%	1.40%	1.03%	25.48%
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
EVK	58 Neutral	€6.67B	15.73	1.08%	8.82%	-5.92%	-58.33%
WCH	58 Neutral	$3.34B	13.86	―	3.77%	-10.63%	-23.15%
VBK	57 Neutral	€972.94M	-7.05	-14.66%	1.12%	8.65%	-379.83%
1COV	52 Neutral	€10.95B	-29.67	-7.19%	―	-5.27%	-75.47%
LXS	45 Neutral	€1.51B	―	-5.69%	0.57%	-6.82%	71.94%

verbio Vereinigte BioEnergie Corporate Events

Verbio Earnings Call: Strategic Wins Amid Financial Struggles

The recent earnings call for Verbio Vereinigte BioEnergie presented a mixed sentiment, with strategic achievements and regulatory advancements being overshadowed by significant financial challenges. While the company expressed optimism about future regulatory support and strategic expansions, current financial struggles, particularly in Europe, remain a substantial concern.